Holi raises €3M for digital obesity treatment platform
Also see more funding coverage: /category/funding/
Founded 2023 · Warsaw, Poland
The European digital health sector is experiencing unprecedented growth, driven by rising healthcare costs and an ageing population seeking accessible treatment solutions. With over 800 million people worldwide living with obesity, the market for digital therapeutic interventions has become increasingly attractive to investors. Warsaw-based Holi has capitalised on this trend, securing €3 million in seed funding to expand its digital treatment platform across Europe.
The round was led by 4growth VC, a Warsaw-based venture capital firm known for backing early-stage European healthtech companies. This investment represents a strategic bet on the growing digital therapeutics market, where traditional pharmaceutical approaches are being complemented by technology-driven solutions.
Seed funding strengthens digital obesity treatment expansion
4growth VC’s decision to lead this round reflects their thesis on digital health disruption in Central and Eastern Europe. The firm has been particularly active in backing companies that address chronic disease management through technology, viewing the obesity treatment market as significantly underserved by traditional healthcare systems.
“We see tremendous potential in Holi’s approach to combining clinical expertise with digital delivery,” said a spokesperson from 4growth VC. “The obesity epidemic requires scalable solutions that can reach patients beyond traditional clinical settings, and Holi’s platform addresses this need directly.”
The investment comes at a time when European regulators are increasingly supportive of digital therapeutic solutions. Recent EU medical device regulations have created clearer pathways for digital health platforms to gain regulatory approval, providing companies like Holi with greater market certainty.
Platform targets underserved European obesity market
Holi’s digital platform differentiates itself in the European market by focusing specifically on obesity treatment through a combination of behavioural therapy, nutrition guidance, and clinical oversight. Unlike many generic wellness apps, Holi’s approach is grounded in clinical methodology and designed to work within existing healthcare systems.
The company plans to use the €3 million funding to expand beyond Poland into other European markets, where obesity rates continue to climb despite traditional treatment approaches proving insufficient. The platform’s digital-first model allows it to overcome geographical barriers that limit access to specialist obesity treatment centres.
“Our goal is to make evidence-based obesity treatment accessible across Europe,” explained Holi’s founding team. “Traditional approaches often fail because they don’t provide the ongoing support and behavioural change tools that patients need for long-term success.”
The funding will also support clinical trials necessary for broader European regulatory approval and integration with national healthcare systems. This represents a critical step for digital therapeutics companies seeking to move beyond consumer-pay models to insurance-reimbursed treatments.
This investment signals growing confidence in European digital therapeutics, particularly for chronic conditions that require long-term management. With healthcare systems across Europe struggling with rising obesity-related costs, solutions like Holi’s may prove essential for sustainable healthcare delivery.
